Top-News
Professionelle Dienstleistungen USA

10x Genomics Inc. News

Aktie
WKN:  A2PPQJ ISIN:  US88025U1097 US-Symbol:  TXG
24,91 €
-0,37 €
-1,46%
07.05.24 14:36:11
Handeln Depot/Watchlist
Aktienanzahl *
104,15 Mio.
Marktkapitalisierung *
2,63 Mrd. €
Streubesitz
-
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 19.01.2024

10x Genomics Inc. News

02.05.24 - PR Newswire
10x Genomics to Present at the BofA Securities 2024 Healthcare Conference
10x Genomics to Present at the BofA Securities 2024 Healthcare Conference PR Newswire
30.04.24 - PR Newswire
10x Genomics Reports First Quarter 2024 Financial Results
10x Genomics Reports First Quarter 2024 Financial Results PR Newswire
10.04.24 - PR Newswire
10x Genomics to Report First Quarter 2024 Financial Results on April 30, 2024
10x Genomics to Report First Quarter 2024 Financial Results on April 30, 2024 PR Newswire
26.03.24 - PR Newswire
10x Genomics Commercially Launches Visium HD Spatial Gene Expression Assay
10x Genomics Commercially Launches Visium HD Spatial Gene Expression Assay PR Newswire
21.03.24 - PR Newswire
10x Genomics Expands Xenium Menu with Multi-Modal Cell Segmentation Kit and Immuno-Oncology Gene Panel
10x Genomics Expands Xenium Menu with Multi-​Modal Cell Segmentation Kit and Immuno-​Oncology Gene Panel PR Newswire
13.03.24 - PR Newswire
10x Genomics Begins Commercial Shipments of Chromium GEM-X Products
10x Genomics Begins Commercial Shipments of Chromium GEM-X Products PR Newswire
20.02.24 - PR Newswire
10x Genomics to Present at the 44th Annual TD Cowen Health Care Conference
10x Genomics to Present at the 44th Annual TD Cowen Health Care Conference PR Newswire
15.02.24 - PR Newswire
10x Genomics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Outlook for 2024
10x Genomics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Outlook for 2024 PR Newswire
07.02.24 - PR Newswire
10x Genomics Expands Leadership in Single Cell Analysis with Launch of GEM-X Technology
10x Genomics Expands Leadership in Single Cell Analysis with Launch of GEM-X Technology PR Newswire
05.02.24 - PR Newswire
10x Genomics to Showcase New Cutting-Edge Technologies and Highlight Innovation Roadmap at 2024 AGBT General Meeting
10x Genomics to Showcase New Cutting-​Edge Technologies and Highlight Innovation Roadmap at 2024 AGBT General Meeting PR Newswire
24.01.24 - PR Newswire
10x Genomics to Report Fourth Quarter and Full Year 2023 Financial Results on February 15, 2024
10x Genomics to Report Fourth Quarter and Full Year 2023 Financial Results on February 15, 2024 PR Newswire
08.01.24 - PR Newswire
10x Genomics Announces Preliminary Fourth Quarter and Full Year 2023 Results
10x Genomics Announces Preliminary Fourth Quarter and Full Year 2023 Results PR Newswire
21.12.23 - PR Newswire
10x Genomics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
10x Genomics to Present at the 42nd Annual J.P. Morgan Healthcare Conference PR Newswire
20.12.23 - PR Newswire
10x Genomics Launches Xenium Catalyst Network
10x Genomics Launches Xenium Catalyst Network PR Newswire
19.12.23 - PR Newswire
Integrative Study Conducted by 10x Genomics Combines Single Cell, Spatial and In Situ Analyses to Investigate Tumor Invasiveness
Integrative Study Conducted by 10x Genomics Combines Single Cell, Spatial and In Situ Analyses to Investigate Tumor Invasiveness PR Newswire
13.12.23 - PR Newswire
High Sensitivity and Specificity of the Xenium Platform from 10x Genomics Outperforms NanoString's CosMx and Vizgen's Merscope in Benchmarking Preprint
High Sensitivity and Specificity of the Xenium Platform from 10x Genomics Outperforms NanoString's CosMx and Vizgen's Merscope in Benchmarking Preprint PR Newswire
07.12.23 - PR Newswire
10x Genomics and NIH CARD to Create Comprehensive Single Cell Atlas of the Human Brain
10x Genomics and NIH CARD to Create Comprehensive Single Cell Atlas of the Human Brain PR Newswire
17.11.23 - PR Newswire
10x Genomics Wins Another Patent Infringement Case Against NanoString Technologies
10x Genomics Wins Another Patent Infringement Case Against NanoString Technologies PR Newswire
06.11.23 - PR Newswire
OWKIN Integrates 10x Genomics Spatial Omics and Single-Cell Technologies to the MOSAIC Study
OWKIN Integrates 10x Genomics Spatial Omics and Single-​Cell Technologies to the MOSAIC Study PR Newswire
02.11.23 - PR Newswire
10x Genomics Reports Third Quarter 2023 Financial Results
10x Genomics Reports Third Quarter 2023 Financial Results PR Newswire

Newssuche

Videos

newspaper
07.05.24 +43,15%
Technical Trading: DAX Long kurzfristig
DAX Long Typ: Turbo Open End WKN: NG8K9X Hebel: 26 Laufzeit: OpenEnd Einstieg: Market ... Mehr »